<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. valued at $20,283.34 on April 24, 2020, for a service agreement with a firm fixed price. Work is performed in Bethesda, Maryland. The order is set to complete by July 19, 2020.</p>
<p>The National Cancer Institute issued a $17,184.96 delivery order to Illumina, Inc. on February 27, 2019, for biological kits. Place of performance is San Diego, CA 92122. The order has a firm fixed price and an ultimate completion date of March 29, 2019.</p>
<p>The National Cancer Institute issued a $118,852.74 delivery order to Illumina, Inc. on February 25, 2021, for biological kits.</p>
<p>Place of performance is San Diego, CA 92122. The order has a firm fixed price and an ultimate completion date of March 31, 2021. The parent vehicle and contracting office are not identified in the source.</p>
<p>The National Cancer Institute issued a $7,826.25 delivery order to Illumina, Inc. on February 9, 2018, for biological products, with ultimate completion on March 9, 2018.</p>
<p>Place of performance is San Diego, CA 92122. The order is firm fixed price with no set-aside designation.</p>
<p>The National Cancer Institute awarded a purchase order to Illumina, Inc. valued at $16,362.77 on February 26, 2020, for a service agreement with a firm fixed price. Work is performed in Bethesda, Maryland, with an ultimate completion date of May 31, 2020. The order procures sequencing-related services or equipment from Illumina's portfolio of genomic analysis technologies and associated support.</p>
<p>The National Cancer Institute issued a $59,413.88 delivery order to Illumina, Inc. on August 6, 2019, for biological kits.</p>
<p>Place of performance is San Diego, CA 92122. Ultimate completion date is September 5, 2019. The order is priced on a firm fixed-price basis with no set-aside used.</p>
<p>The National Cancer Institute issued an $85,480.76 delivery order to Illumina, Inc. on April 6, 2021, for biological kits.</p>
<p>Place of performance is San Diego, CA 92122. The order is firm fixed price with an ultimate completion date of May 5, 2021. The source does not identify the parent vehicle under which this delivery order was issued.</p>
<p>The National Cancer Institute issued a $105,365.88 delivery order to Illumina, Inc. on August 5, 2020, for reagents and consumables.</p>
<p>Place of performance is San Diego, CA 92122. Ultimate completion date is September 4, 2020. The order is priced on a firm fixed-price basis with no set-aside applied.</p>
<p>The National Cancer Institute issued a delivery order to Illumina, Inc. on January 16, 2020, for Illumina reagents and consumables with a ceiling value of $60,479.90.</p>
<p>Place of performance is San Diego, CA 92122. The order is firm fixed price with ultimate completion on February 15, 2020. No set-aside was used.</p>
<p>The National Cancer Institute issued a $25,618.32 delivery order to Illumina, Inc. on August 15, 2018, with final completion on August 22, 2018.</p>
<p>Place of performance is San Diego, CA 92122. The order is firm fixed price with no set-aside. The source does not identify the parent IDIQ or vehicle under which this delivery order was issued.</p>